CLASS II Drug recall · Reported 13 Sep 2023 · FDA Enforcement Report

Sodium Fluoride 1.1%, Sodium Fluoride Prescription Dental recalled

Avkare is recalling Sodium Fluoride 1.1%, Sodium Fluoride Prescription Dental Toothpaste, 5000 ppm Fluoride. The recall was initiated on 11 Aug 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # P23025 Exp. 02/24/2025
NDC42291-741
UPC0342291741515
Quantity recalled35,184 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1146-2023
FDA event ID
92868
Recalling firm
Avkare, Pulaski, TN
Manufacturer
AvKARE
Classification
Class II
Status
Terminated
Recall initiated
11 Aug 2023
FDA classified
7 Sep 2023
Reported
13 Sep 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

11 Aug 2023Recall initiated by company
7 Sep 2023Classified by FDA+27 days
13 Sep 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Product as listed by the FDA

Sodium Fluoride 1.1%, SODIUM FLUORIDE Prescription Dental Toothpaste, 5000 ppm Fluoride Plus Mild Cleaning System Spearmint NET WT. 1.8 OZ. (51g), Rx only, NDC 42291-741-51, Manufactured for: AvKARE Pulaski, TN 38478

Where it was distributed

Affected product was distributed to nineteen (19) consignees within the united states.

Questions about this recall

Why was it recalled?

Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Which lots are affected?

Lot # P23025 Exp. 02/24/2025

Where was it sold?

Affected product was distributed to nineteen (19) consignees within the united states.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 92868

This product is part of a recall event; the main page for the event is Capsaicin Cream 0.025%, External Analgesic Cream recalled by AVKARE.

ReportedClassRecallCompanyReasonWhere
CLASS IICapsaicin Cream 0.025%, External Analgesic Cream recalled by AVKARECapsaicinAvkarePackaging DefectsTN

More recalls from Avkare

All 62
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine HclAvKAREPotency & AssayNationwide
DrugCLASS IIRosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatinAvKAREPotency & AssayNationwide
DrugCLASS IINorgestimate and Ethinyl Estradiol Tablets recalled by AvKARENorgestimate And Ethinyl EstradiolAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 100 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 50 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide

Other Sodium Fluoride recalls

All 4